Mechanistically, both tumor control and anti-tumoral CD8+ T cell responses depended on enhanced inflammasome activation in Tmem176b−/− mice since they were reversed by IL-1β blockade and Casp1 deletion. The gene discussed is CD8A; the disease is neoplasm.